Literature DB >> 20173772

Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic.

R Paul Robertson, David M Kendall, Elizabeth R Seaquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20173772     DOI： 10.1038/nrendo.2010.2

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

2.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Authors:  H C Gerstein; S Yusuf; J Bosch; J Pogue; P Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

3.  The burden of mortality attributable to diabetes: realistic estimates for the year 2000.

Authors:  Gojka Roglic; Nigel Unwin; Peter H Bennett; Colin Mathers; Jaakko Tuomilehto; Satyajit Nag; Vincent Connolly; Hilary King
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

4.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

5.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Authors:  William C Knowler; Sarah E Fowler; Richard F Hamman; Costas A Christophi; Heather J Hoffman; Anne T Brenneman; Janet O Brown-Friday; Ronald Goldberg; Elizabeth Venditti; David M Nathan
Journal:  Lancet       Date:  2009-10-29       Impact factor: 79.321

8.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

Authors:  Guangwei Li; Ping Zhang; Jinping Wang; Edward W Gregg; Wenying Yang; Qiuhong Gong; Hui Li; Hongliang Li; Yayun Jiang; Yali An; Ying Shuai; Bo Zhang; Jingling Zhang; Theodore J Thompson; Robert B Gerzoff; Gojka Roglic; Yinghua Hu; Peter H Bennett
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

9.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 10.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.

Authors:  Clare L Gillies; Keith R Abrams; Paul C Lambert; Nicola J Cooper; Alex J Sutton; Ron T Hsu; Kamlesh Khunti
Journal:  BMJ       Date:  2007-01-19
  10 in total
  1 in total

1.  System accuracy evaluation of the GlucoRx nexus voice TD-4280 blood glucose monitoring system.

Authors:  Muhammad Khan; Keith Broadbent; Mike Morris; David Ewins; Franklin Joseph
Journal:  Dis Markers       Date:  2014-10-13       Impact factor: 3.434
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.